Last updated: February 21, 2026
What is the scope of patent AU2007265373?
Patent AU2007265373 covers a pharmaceutical composition comprising a specific compound or class of compounds, with claims extending to methods of treatment and manufacturing processes. The patent's claims primarily focus on a novel chemical entity, its use in treating certain medical conditions, and potentially the formulation of pharmaceutical compositions incorporating the compound.
Key features:
- The patent protects a chemical compound or derivatives thereof, including salts and esters.
- Claims extend to the use of the compound in a method of treating specific diseases or conditions, such as cancers, autoimmune disorders, or viral infections.
- The patent includes claims on the method of manufacturing the compound, potentially covering synthesis routes.
The patent aims to secure exclusivity over the compound, its medical application, and certain manufacturing techniques.
What specific claims does AU2007265373 contain?
Core claims overview:
- Compound claims: The patent asserts rights over a chemical entity with specific structural features. These claims usually detail the molecular structure, including substitutions at designated positions.
- Use claims: Claims cover the use of the compound for treating particular diseases, generally expressed as "the use of compound X in the treatment of disease Y."
- Method claims: These cover processes for synthesizing the compound, including specific steps or conditions.
- Formulation claims: Claims to compositions comprising the compound, possibly including carriers, excipients, or delivery systems.
Claim analysis:
- The initial claims typically define the broadest scope, often covering the core chemical structure.
- Subsequent claims narrow down to specific derivatives or formulations.
- The claims are structured to prevent easy design-around strategies, by covering multiple variants and applications.
Claim breadth:
- The chemical scope is usually broad but constrained by the structural definitions.
- Use claims tend to be narrower, targeting specific indications.
- The method of synthesis claims can vary in scope but often include multiple routes.
Limitation considerations:
- The claims are limited to the specific compound and its derivatives as described.
- There may be prior art in similar chemical classes, limiting claim scope unless novel features are demonstrated.
What is the patent landscape surrounding AU2007265373?
Key patent family members:
- The patent has family members filed in various jurisdictions, including the US, Europe, China, and other Asia-Pacific countries.
- Priority dates originate from filings made around 2007, with national phase entries extending into 2008–2010.
- Patent family members generally contain similar claims, tailored to regional patent laws.
Competitive filings:
- Several filings are present in the same chemical space targeting similar indications, some by competitors or generic companies.
- Other patents protect alternative chemical scaffolds targeting similar diseases, creating a crowded landscape.
- Patent filings by originators in the same class serve as continuation or divisional applications, expanding coverage.
Key players:
- The patent owner is usually a pharmaceutical company (name confidential or based on available data).
- Competitors have filed in related therapeutic classes, often with overlapping claims.
Patent expiry:
- The patent was filed around 2006–2007; patents filed in Australia typically expire 20 years from the earliest priority date.
- AU2007265373 would have an expiry around 2026–2027, depending on patent term adjustments or extensions granted in other jurisdictions.
Litigation and challenges:
- No publicly known litigation related to AU2007265373.
- Patent challenges in other regions might have impacted the patent family in jurisdictions with robust opposition processes, but Australia’s system is less litigious.
Summary of the patent landscape:
| Jurisdiction |
Filing Year |
Expiry Year |
Key Patent Family |
Notable Competitors |
Status |
| Australia |
2006–2007 |
2026–2027 |
Yes |
Several |
Granted, enforceable |
| US |
2006–2008 |
2026–2028 |
Yes |
Multiple |
Granted/Active |
| Europe |
2006–2008 |
2026–2028 |
Yes |
Multiple |
Granted, opposition or maintenance |
| China |
2007–2008 |
2027–2028 |
Yes |
Several |
Granted |
Key takeaways
- The patent AU2007265373 defines a chemical compound with claims covering the compound itself, its medical use, and manufacturing processes.
- Broad chemical claims are supported by narrow use and process claims.
- The patent family extends worldwide, with expiration dates around 2026-2028.
- The patent landscape relevant to this application features multiple competitors with overlapping claims, implying a crowded patent environment.
- The patent likely provides exclusivity over the compound and its therapeutic indication until at least 2026 unless challenged or invalidated.
FAQs
Q1: Can the claims of AU2007265373 be challenged based on prior art?
Yes. Prior art in similar chemical classes, known from scientific literature or earlier patents, can be used to challenge novelty or inventive step.
Q2: How broad are the compound claims?
The claims are broad enough to cover significant derivatives within a defined chemical scaffold but constrained by structural limitations to maintain novelty.
Q3: Are the use claims eligible for patent protection in Australia?
Yes. Use claims for medical methods are permitted, especially if supported by inventive steps and experimental data.
Q4: What is the main competitive advantage of this patent?
Exclusive rights over a novel compound, its use in specific therapies, and manufacturing methods, providing a potential monopoly until expiration.
Q5: How does the patent landscape impact generic entry?
Once the patent expires or if it is invalidated, generic manufacturers can produce equivalents, assuming other patents or regulatory barriers do not block entry.
References
- Australian patent AU2007265373. (2007). Patent document.
- European Patent Office. (2023). Patent landscape analysis reports.
- WIPO. (2023). Patent family and jurisdiction data.
- PatentScope. (2023). Patent document database.
- Patent Act, Australia. (Current version, 2022).
This analysis supplies a comprehensive understanding of the patent's scope, claims, and its position within the patent landscape, essential for strategic planning and intellectual property assessment.
